This inventor holds 1 USPTO granted patent. Top assignees: Institute of Pharmacology and Toxicology Academy of Military Medical Science P.l.a. China, Kpc Pharmaceuticals, Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Na Xing: Innovator in Pharmaceutical Chemistry
Introduction
Na Xing is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pegylated artesunate derivatives. His research focuses on enhancing the efficacy and stability of pharmaceutical compounds.
Latest Patents
Na Xing holds a patent for a pegylated artesunate derivative, which is a pharmaceutical composition with notable applications. This pegylated artesunate derivative is represented by a specific general formula and exhibits activity comparable to that of artesunate. It also boasts increased water solubility and stability, along with an extended half-life in vivo. This innovation has the potential to improve treatment outcomes for various medical conditions.
Career Highlights
Throughout his career, Na Xing has worked with reputable organizations, including KPC Pharmaceuticals, Inc. and the Institute of Pharmacology and Toxicology at the Academy of Military Medical Science, PLA China. His experience in these institutions has allowed him to develop and refine his expertise in pharmaceutical research and development.
Collaborations
Na Xing has collaborated with notable colleagues in his field, including Sicheng Li and Qingbin Meng. These partnerships have contributed to the advancement of his research and the successful development of his patented innovations.
Conclusion
Na Xing's contributions to pharmaceutical chemistry, particularly through his pegylated artesunate derivative, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and pharmaceutical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile